China Shineway Pharmaceutical Group Limited

HKSE 2877.HK

China Shineway Pharmaceutical Group Limited Total Assets for the year ending December 31, 2023: USD 1.35 B

China Shineway Pharmaceutical Group Limited Total Assets is USD 1.35 B for the year ending December 31, 2023, a 13.05% change year over year. Total assets are the total value of all assets owned by a company, representing its resources.

China Shineway Pharmaceutical Group Limited Total Assets for the year ending December 31, 2022 was USD 1.19 B, a 5.21% change year over year.
China Shineway Pharmaceutical Group Limited Total Assets for the year ending December 31, 2021 was USD 1.13 B, a 2.59% change year over year.
China Shineway Pharmaceutical Group Limited Total Assets for the year ending December 31, 2020 was USD 1.11 B, a 7.91% change year over year.
China Shineway Pharmaceutical Group Limited Total Assets for the year ending December 31, 2019 was USD 1.02 B, a 4.62% change year over year.

Key data

Date	Total Assets	Current Liabilities	Total Non-Current Liabilities	Shareholders' Equity

HKSE: 2877.HK

China Shineway Pharmaceutical Group Limited

CEO	Mr. Zhenjiang Li
IPO Date	Dec. 2, 2004
Location	China
Headquarters	No. 168 Shiluan Street
Employees	3,232
Sector	Health Care
Industries Pharmaceuticals

Description

China Shineway Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and trade of Chinese medicines in the People's Republic of China and Hong Kong. The company offers modern Chinese medicines in the form of soft capsules, granules, and injections, as well as TCM Formula Granules in various therapeutic areas, including cardio-cerebrovascular, anti-viral, orthopedics, pediatrics, gynecology, and gastroenterology. It also trades in agricultural products. The company was incorporated in 2004 and is headquartered in Shijiazhuang, the People's Republic of China. China Shineway Pharmaceutical Group Limited is a subsidiary of Forway Investment Limited.

Key trends

Past 5 years